Last reviewed · How we verify
NCT03666468: G4MER
The Gaming for Medical Education Research (G4MER) Program
NA trial testing PlayMed in Education, Medical in 264 participants. Status unknown.
28 February 2022
Quick facts
| Lead sponsor | The University of New South Wales |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 264 |
| Start date | 3 July 2017 |
| Primary completion | 28 February 2022 |
| Estimated completion | 30 April 2022 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- PlayMed
- Online Package
- Paper Guidelines
Conditions studied
- Education, Medical — all drugs for Education, Medical →
Sponsor
The University of New South Wales
Who can join
Adults 20 to 99, any sex, with Education, Medical. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "G4MER" Program aims to investigate whether serious games add value to medical education in comparison to an online learning package or clinical practice guidelines. The investigators will perform a series of investigator-blinded randomised control trials on doctors, nurses, and medical students at Sydney Children's Hospital. Participants will be given access to their randomly allocated intervention for 8 weeks or 5 days, and will be assessed using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations. Participant attitudes will also be assessed through a mixed-methods questionnaire.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03666468
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Education, Medical
Currently open trials in the same condition.
- NCT07419984 — Gamified Neurology Grand Rounds · NA · active not recruiting
- NCT05817370 — Implementation of Anal Cancer Screening and Treatment in Nigeria · NA · recruiting
Other The University of New South Wales trials
Trials by the same sponsor.
- NCT07057219 — Steps Against the Burden of Parkinson's Disease · NA · recruiting
- NCT06898853 — The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes · NA · not yet recruiting
- NCT06070818 — Healthy Body & Mind Program for Older Adults Living With Osteoarthritis and Cognitive Decline · NA · unknown
- NCT06119243 — Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study · recruiting
- NCT03809143 — Community Studies of Long Acting Buprenorphine (CoLAB) · Phase 3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03666468 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of New South Wales
- Last refreshed: 31 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03666468.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing